---
title: Eurofins Central Laboratory vs SoCal Biosciences, Inc.
slug_a: eurofins
slug_b: socalbiosci
site: cro
review_signal_gate: closed
canonical_path: /compare/eurofins/socalbiosci
---

# Eurofins Central Laboratory vs SoCal Biosciences, Inc.

Side-by-side profile data from each company listing on this directory.

## Eurofins Central Laboratory

- Profile: [/companies/eurofins](/companies/eurofins)

Eurofins Central Laboratory — Global network of over 950 laboratories across 57 countries offering comprehensive contract research, testing, and manufacturing services including BioPharma discovery, bioanalysis, Phase I clinics, CDMO, central laboratory services, and specialized analytical testing.

Services: 7. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Bioanalysis
- Phase I Clinical Trials
- Central Laboratory Services
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Genomics & Sequencing Services

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)

## SoCal Biosciences, Inc.

- Profile: [/companies/socalbiosci](/companies/socalbiosci)

SoCal Biosciences, Inc. — San Diego-based bioanalytical CRO specializing in assay development and analysis for mRNA, oligonucleotides, and large molecules across discovery through clinical development phases.

Services: 8. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Analytical Method Development & Validation
- Translational Research

### Modalities

- Biologics (Other)
- Oligonucleotide
- mRNA

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)